ID

25181

Descrição

CALGB 50901 New Malignancy Form Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9F505C29-ACEA-78C3-E040-BB89AD433B18

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9F505C29-ACEA-78C3-E040-BB89AD433B18

Palavras-chave

  1. 19/09/2012 19/09/2012 -
  2. 28/08/2017 28/08/2017 -
Transferido a

28 de agosto de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0 Legacy

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

CALGB 50901 New Malignancy Form

Instructions: 1. Report any malignancy that is: A new histologic type A previous histologic type that is judged to be a new primary A new secondary malignancy related to cancer treatment, including AML/MDS. Recurrence of a previous malignancy 2. Submit pathology and/or cytogenetic report(s) documenting the new primary or secondary malignancy. 3. Do not use this form to report recurrences of current lymphoma. 4. All new malignancies must also be reported to NCI/CTEP via the AdEERS application.

New Malignancy
Descrição

New Malignancy

Alias
UMLS CUI-1
C4266456
UMLS CUI-2
C0024301
New Malignancy Type
Descrição

DiseaseorDisorderNewDiseaseProgressionDiagnosisType

Tipo de dados

integer

Alias
NCI Thesaurus ObjectClass
C2991
NCI Thesaurus Property
C25586
NCI Thesaurus Property-2
C17747
NCI Thesaurus Property-3
C15220
NCI Thesaurus ValueDomain
C25284
UMLS CUI [1,1]
C4266456
UMLS CUI [1,2]
C0332307
UMLS CUI [2]
C0242656
Specify Type
Descrição

MalignantDiseaseOtherPresentSpecify

Tipo de dados

text

Alias
NCI Thesaurus ObjectClass
C14143
NCI Thesaurus ObjectClass-2
C2991
NCI Thesaurus Property
C17649
NCI Thesaurus Property-2
C25626
NCI Thesaurus ValueDomain
C25685
UMLS CUI [1,1]
C4266456
UMLS CUI [1,2]
C0332307
Specify histologic type
Descrição

Histologic Type

Tipo de dados

text

Alias
NCI Thesaurus ValueDomain
C25685
NCI Thesaurus ObjectClass
C3262
NCI Thesaurus Property
C25526
NCI Thesaurus Property-2
C25161
UMLS CUI [1,1]
C0449574
UMLS CUI [1,2]
C4266456

Similar models

Instructions: 1. Report any malignancy that is: A new histologic type A previous histologic type that is judged to be a new primary A new secondary malignancy related to cancer treatment, including AML/MDS. Recurrence of a previous malignancy 2. Submit pathology and/or cytogenetic report(s) documenting the new primary or secondary malignancy. 3. Do not use this form to report recurrences of current lymphoma. 4. All new malignancies must also be reported to NCI/CTEP via the AdEERS application.

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
New Malignancy
C4266456 (UMLS CUI-1)
C0024301 (UMLS CUI-2)
Item
New Malignancy Type
integer
C2991 (NCI Thesaurus ObjectClass)
C25586 (NCI Thesaurus Property)
C17747 (NCI Thesaurus Property-2)
C15220 (NCI Thesaurus Property-3)
C25284 (NCI Thesaurus ValueDomain)
C4266456 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
Code List
New Malignancy Type
CL Item
New Primary Malignancy (1)
CL Item
New Secondary Malignancy (2)
CL Item
Recurrence Of Previous Malignancy (3)
Type
Item
Specify Type
text
C14143 (NCI Thesaurus ObjectClass)
C2991 (NCI Thesaurus ObjectClass-2)
C17649 (NCI Thesaurus Property)
C25626 (NCI Thesaurus Property-2)
C25685 (NCI Thesaurus ValueDomain)
C4266456 (UMLS CUI [1,1])
C0332307 (UMLS CUI [1,2])
Histologic Type
Item
Specify histologic type
text
C25685 (NCI Thesaurus ValueDomain)
C3262 (NCI Thesaurus ObjectClass)
C25526 (NCI Thesaurus Property)
C25161 (NCI Thesaurus Property-2)
C0449574 (UMLS CUI [1,1])
C4266456 (UMLS CUI [1,2])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial